Seoulin Bioscience Co.Ltd - Asset Resilience Ratio

Latest as of December 2025: 20.42%

Seoulin Bioscience Co.Ltd (038070) has an Asset Resilience Ratio of 20.42% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Seoulin Bioscience Co.Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩24.26 Billion
≈ $16.44 Million USD Cash + Short-term Investments

Total Assets

₩118.80 Billion
≈ $80.51 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Seoulin Bioscience Co.Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Seoulin Bioscience Co.Ltd asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Seoulin Bioscience Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Seoulin Bioscience Co.Ltd (038070) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩24.26 Billion 20.42%
Total Liquid Assets ₩24.26 Billion 20.42%

Asset Resilience Insights

  • Good Liquidity Position: Seoulin Bioscience Co.Ltd maintains a healthy 20.42% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Seoulin Bioscience Co.Ltd Industry Peers by Asset Resilience Ratio

Compare Seoulin Bioscience Co.Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Tubize-Fin
BR:TUB
Biotechnology 2.50%
Dianthus Therapeutics Inc.
NASDAQ:DNTH
Biotechnology 63.98%
Tango Therapeutics Inc
NASDAQ:TNGX
Biotechnology 62.24%
Damora Therapeutics, Inc.
NASDAQ:DMRA
Biotechnology 0.00%
Wecome Pharmaceutical Co Ltd
SHE:300878
Biotechnology 0.67%
Tectonic Therapeutic, Inc.
NASDAQ:TECX
Biotechnology 86.66%
Relmada Therapeutics Inc
NASDAQ:RLMD
Biotechnology 95.25%
MediWound Ltd
F:M8W
Biotechnology 56.04%

Annual Asset Resilience Ratio for Seoulin Bioscience Co.Ltd (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Seoulin Bioscience Co.Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 20.42% ₩24.26 Billion
≈ $16.44 Million
₩118.80 Billion
≈ $80.51 Million
-1.59pp
2024-12-31 22.02% ₩22.36 Billion
≈ $15.15 Million
₩101.52 Billion
≈ $68.80 Million
-6.79pp
2023-12-31 28.81% ₩32.88 Billion
≈ $22.28 Million
₩114.10 Billion
≈ $77.32 Million
-10.33pp
2022-12-31 39.14% ₩52.79 Billion
≈ $35.78 Million
₩134.87 Billion
≈ $91.40 Million
-14.52pp
2021-12-31 53.66% ₩73.28 Billion
≈ $49.66 Million
₩136.57 Billion
≈ $92.55 Million
+29.56pp
2020-12-31 24.10% ₩18.86 Billion
≈ $12.78 Million
₩78.25 Billion
≈ $53.03 Million
-3.21pp
2019-12-31 27.30% ₩22.04 Billion
≈ $14.93 Million
₩80.71 Billion
≈ $54.69 Million
+13.63pp
2018-12-31 13.68% ₩9.73 Billion
≈ $6.59 Million
₩71.11 Billion
≈ $48.19 Million
-1.55pp
2017-12-31 15.23% ₩10.82 Billion
≈ $7.33 Million
₩71.04 Billion
≈ $48.14 Million
-9.54pp
2016-12-31 24.77% ₩16.46 Billion
≈ $11.16 Million
₩66.47 Billion
≈ $45.05 Million
-4.59pp
2015-12-31 29.36% ₩19.41 Billion
≈ $13.15 Million
₩66.10 Billion
≈ $44.80 Million
-2.45pp
2014-12-31 31.81% ₩19.32 Billion
≈ $13.09 Million
₩60.72 Billion
≈ $41.15 Million
-1.62pp
2013-12-31 33.44% ₩20.19 Billion
≈ $13.68 Million
₩60.39 Billion
≈ $40.92 Million
--
pp = percentage points

About Seoulin Bioscience Co.Ltd

KQ:038070 Korea Biotechnology
Market Cap
$24.32 Million
₩35.88 Billion KRW
Market Cap Rank
#24570 Global
#1760 in Korea
Share Price
₩4065.00
Change (1 day)
+0.00%
52-Week Range
₩4010.00 - ₩6940.00
All Time High
₩36786.63
About

Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and fun… Read more